Can caffeine chewing gum and watching and imagining golf movements improve putting and iron shot performance after mental fatigue?

ISRCTN ISRCTN40730979
DOI https://doi.org/10.1186/ISRCTN40730979
Sponsors Hainan Normal University, Macao Polytechnic University
Funder Hainan Normal University
Submission date
11/10/2026
Registration date
13/10/2026
Last edited
12/10/2026
Recruitment status
Not yet recruiting
Overall study status
Ongoing
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Xianfei Wang
Public, Scientific, Principal investigator

3 Xiaoji No.1 Rd, Mei Lan Qu
Haikou
571127
China

Phone +86 18976037604
Email 090206@hainnu.edu.cn
Mr Shiao Zhao
Scientific, Public, Principal investigator

5HV2+CP8, R. de Luís Gonzaga Gomes
Macau
999078
China

Phone +853 19358564748
Email zhaoshiao530@gmail.com
Dr Guowen Ai
Public, Scientific, Principal investigator

3 Xiaoji No.1 Rd, Mei Lan Qu
Haikou
571127
China

Phone +86 15708918980
Email 920538@hainnu.edu.cn
Prof Ziheng Ning
Public, Scientific, Principal investigator

5HV2+CP8, R. de Luís Gonzaga Gomes
Macau
999078
China

Phone +853 14714947917
Email zhning@mpu.edu.mo

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingBlinded (masking used)
ControlPlacebo
AssignmentCrossover
PurposeTreatment, Acute effects of caffeine chewing gum and asynchronous action observation and motor imagery (A-AOMI), administered independently and in combination, on golf putting accuracy and 7-iron performance following experimentally induced mental fatigue in novice golfers.
Scientific titleEffects of caffeine chewing gum and asynchronous action observation and motor imagery on golf putting and 7-iron performance following mental fatigue in novice golfers: a randomised, placebo-controlled, 2 × 2 factorial, four-period crossover trial
Study objectives The primary objective of this study is to investigate the acute effects of caffeine chewing gum (200 mg) and asynchronous action observation and motor imagery (A-AOMI), administered separately and in combination, on golf putting accuracy and 7-iron performance following experimentally induced mental fatigue in novice golfers.

Specifically, the study aims to:
1. Examine the main effect of caffeine chewing gum on golf putting and 7-iron performance.
2. Examine the main effect of A-AOMI on golf putting and 7-iron performance.
3. Investigate the interaction between caffeine chewing gum and A-AOMI to determine whether their combined effects differ from the sum of their individual effects.
4. Explore subjective mental fatigue, physiological responses, and individual differences in baseline mental representation as supplementary outcomes or explanatory factors.
Ethics approval(s)

Approved 21/08/2026, Teaching Committee of the Faculty of Health Sciences and Sports, Macao Polytechnic University (5HV2+CP8, R. de Luís Gonzaga Gomes, Macau, 999078, China; +853 8599 6333; tlsiu@mpu.edu.mo), ref: FCSD/DPPESS-006/2026

Health condition(s) or problem(s) studiedAcute mental fatigue and golf-specific motor performance in healthy novice golfers.
InterventionThis study will employ a randomised, placebo-controlled, 2 × 2 factorial, four-condition crossover design to investigate the acute effects of caffeine chewing gum and asynchronous action observation and motor imagery (A-AOMI) on golf performance following mental fatigue.
Each participant will complete one familiarisation and baseline assessment session followed by four experimental sessions, separated by a planned 7-day washout period. The order of the four experimental conditions will be assigned using a balanced randomisation sequence.
The four experimental conditions will be:
1. CAF + A-AOMI: 200 mg caffeine chewing gum combined with task-specific A-AOMI.
2. CAF + CON: 200 mg caffeine chewing gum combined with a neutral control task.
3. PLA + A-AOMI: Placebo chewing gum combined with task-specific A-AOMI.
4. PLA + CON: Placebo chewing gum combined with a neutral control task.
At each experimental visit, participants will complete baseline assessments and a standardised pre-intervention warm-up assessment consisting of five putts and three 7-iron shots. Participants will then undertake a 30-minute Stroop task to induce mental fatigue. Following the Stroop task and a standardised seated recovery assessment, participants will chew either caffeine or placebo gum for 10 minutes and then discard it.
The A-AOMI intervention will consist of two task-specific segments, each lasting 3.5 minutes. Each segment will include brief technical instructions, first-person action observation, third-person action observation, and subsequently guided first-person kinaesthetic motor imagery. The neutral control tasks will be matched in duration without providing golf-specific action observation or motor imagery instructions.
Participants will first complete the 3.5-minute putting A-AOMI or neutral control task, immediately followed by 20 putts. After a standardised transition with two to three practice swings without hitting a ball, participants will complete the 3.5-minute 7-iron A-AOMI or neutral control task, immediately followed by 10 7-iron shots.
Putting performance will be assessed using ball-position coordinates (X and Y) and derived accuracy and consistency measures. No ZZT-derived putting measurements will be collected. The 7-iron outcomes will be recorded using FlightScope launch-monitor technology, including ball speed, clubhead speed, carry distance, total distance, smash factor, and lateral deviation.
Heart rate and heart rate variability will be assessed during three standardised seated recording periods: before the Stroop task, after the Stroop task, and following completion of the golf performance tests. Subjective mental fatigue, intervention adherence, and adverse events will also be assessed. Baseline mental representation will be assessed once during the initial baseline session only.
Intervention typeBehavioural
Primary outcome measure(s)
  1. Putting accuracy measured using Mean Radial Error (MRE) of golf putting, calculated as the mean Euclidean distance between the final ball position and the target using X and Y coordinates across 20 putts. Measured immediately after the task-specific intervention during each of the four experimental sessions, at the initial baseline assessment and immediately following the putting-specific intervention during each of the four experimental sessions (Periods 1–4, approximately 7 days apart)
  2. 7-iron ball speed measured using a FlightScope launch monitor to calculate mean ball speed across 10 standardised 7-iron shots, at the initial baseline assessment and immediately following the 7-iron-specific intervention during each of the four experimental sessions (Periods 1–4, approximately 7 days apart)
Key secondary outcome measure(s)
Completion date25/11/2026

Eligibility

Participant type(s)
Age groupAdult
Lower age limit18 Years
Upper age limit25 Years
SexAll
Target sample size at registration16
Key inclusion criteria1. Healthy adults aged 18–25 years
2. Novice or beginner golfers who are able to safely perform standardised golf putting and 7-iron shots
3. Normal or corrected-to-normal vision and the ability to distinguish the colours used in the Stroop task
4. Able to understand and follow the experimental procedures, including the mental fatigue task, chewing gum intervention, and action observation and motor imagery instructions
5. Willing and able to attend one familiarisation/baseline session and four experimental sessions, with a planned 7-day washout period between consecutive experimental sessions
6. Able to comply with the pre-test restrictions, including abstaining from caffeine and alcohol for 24 hours before each experimental session
7. Willing to provide written informed consent before participation
Key exclusion criteria1. History of cardiovascular disease, uncontrolled hypertension, clinically significant cardiac arrhythmias, epilepsy, or other medical conditions that may increase the risks associated with caffeine intake or physical activity
2. Known hypersensitivity, allergy, or intolerance to caffeine or any ingredient in the experimental chewing gum
3. Current use of medications that may interact with caffeine or substantially affect central nervous system activity, heart rate, or exercise responses
4. Musculoskeletal injuries or physical limitations that prevent safe performance of golf putting or 7-iron shots
5. Neurological or visual impairments that substantially interfere with performing the Stroop task or following action observation and motor imagery instructions
6. Pregnancy or breastfeeding
7. Oral or temporomandibular conditions that prevent safe chewing of gum
8. Inability or unwillingness to comply with the experimental schedule, washout periods, or pre-test restrictions
9. Participation in another intervention study that could interfere with the outcomes of the present trial
Date of first enrolment20/10/2026
Date of final enrolment23/10/2026

Locations

Countries of recruitment

  • China

Study participating centres

Results and Publications

Individual participant data (IPD) Intention to shareNo

Editorial Notes

12/10/2026: Study’s existence confirmed by the Teaching Committee of the Faculty of Health Sciences and Sports, Macao Polytechnic University, China.